Case Study:
Integrated performance analysis with AI
How AI is answering commercial teams questions immediately saving analytics team times
Many commercial teams have analytics teams supporting them to whom they send questions to. For several of our clients, the main team is not large enough to answer all of the requests and they often have teams of data scientists in India that they send the questions to. But even then, it is humans doing the analysis. The majority of requests take hours to days to calculate the answers. We did a project for one client in which they were getting almost 300 requests a week and the backlog of questions to answer was piling up. The answer – utilising a combination of NLP and ML to automatically calculate the answers in a platform in which you could put the questions in natural language as you would with a human, as well as deep dive interrogations as to why, and automatically create C-Suite ready PowerPoint slides and excels as needed – in 5-15 mins.
The Client
- Small analytics team for all products
- Internal data is not integrated (program data, flow data etc)
- Constrains efficient use of resources
The Solution
- Data-driven Artificial Intelligence to crunch data and speed up time to answer questions to allow the human team to focus on the strategic insights
The Outcome
- After data is wrangled and combined, can be set up to pipe data into the platform. Then it takes 5-15 mins to answer questions and have visualisations of the answers as well.
- Game. Changed!
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.

We’re Doing AI” Is Not a Board Answer
There is a moment I have seen play out in pharmaceutical boardrooms again and again. It usually comes in the second half of the agenda,

Why Most AI Governance Frameworks Are the Wrong Fit for Pharma
Most pharmaceutical organizations now have some form of AI governance. On paper, that sounds reassuring. In practice, it often means a policy document, a review

Why Most Pharma AI Strategies Fail the CFO Test
Most pharmaceutical organizations do not struggle to explain what their AI programmes do. They struggle to explain, in financial terms, why those programmes deserve sustained